Mapatumumab News
Most Popular Mapatumumab Story
HGS cancer drug fails another mid-stage trial
Human Genome Sciences (HGSI) says that a combination of Velcade and its experimental cancer drug mapatumumab (HGS-ETR1) flunked a mid-stage trial for multiple myeloma, with the data failing to Read more...
Latest Headlines
- June 9, 2010
- March 17, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
